Meta-analysis of the predictive value of C-reactive protein for infectious complications in abdominal surgery

British Journal of Surgery

Volumn 102, Issue 6, 2015, Pages 590-598

  Adamina, M ^a   Steffen, T ^b   Tarantino, I ^b   Beutner, U ^b   Schmied, B M ^b   Warschkow, R ^a,c  

^a CANTONAL HOSPITAL WINTERTHUR   (Switzerland)

^b CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN;

ABDOMINAL SURGERY; BLOOD; EARLY DIAGNOSIS; HUMAN; META ANALYSIS; METABOLISM; PREDICTIVE VALUE; SURGICAL WOUND INFECTION;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DIGESTIVE SYSTEM SURGICAL PROCEDURES; EARLY DIAGNOSIS; HUMANS; PREDICTIVE VALUE OF TESTS; SURGICAL WOUND INFECTION;

EID: 84927578333     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9756     Document Type: Review

References (54)

1. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et-al.; Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368-1377.
2. Puskarich MA, Marchick MR, Kline JA, Steuerwald MT, Jones AE,. One year mortality of patients treated with an emergency department based early goal directed therapy protocol for severe sepsis and septic shock: a before and after study. Crit Care 2009; 13: R167.
3. Rivers EP,. Point: adherence to early goal-directed therapy: does it really matter? Yes. After a decade, the scientific proof speaks for itself. Chest 2010; 138: 476-480.
4. Fobi MA, Lee H, Holness R, Cabinda D,. Gastric bypass operation for obesity. World J Surg 1998; 22: 925-935.
5. Marshall JS, Srivastava A, Gupta SK, Rossi TR, Debord JR,. Roux-en- Y gastric bypass leak complications. Arch Surg 2003; 138: 520-523.
6. Adamina M, Kehlet H, Tomlinson GA, Senagore AJ, Delaney CP,. Enhanced recovery pathways optimize health outcomes and resource utilization: a meta-analysis of randomized controlled trials in colorectal surgery. Surgery 2011; 149: 830-840.
7. Chromik AM, Endter F, Uhl W, Thiede A, Reith HB, Mittelkötter U,. Pre-emptive antibiotic treatment vs 'standard' treatment in patients with elevated serum procalcitonin levels after elective colorectal surgery: a prospective randomised pilot study. Langenbecks Arch Surg 2006; 391: 187-194.
8. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J,. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004; 39: 206-217.
9. Sponholz C, Sakr Y, Reinhart K, Brunkhorst F,. Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature. Crit Care 2006; 10: R145.
10. Tillett WS, Francis T,. Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J Exp Med 1930; 52: 561-571.
11. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW,. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999; 19: 972-978.
12. Pepys MB, Hirschfield GM,. C-reactive protein: a critical update. J Clin Invest 2003; 111: 1805-1812.
13. Mayer J, Rau B, Gansauge F, Beger HG,. Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications. Gut 2000; 47: 546-552.
14. Mofidi R, Duff MD, Wigmore SJ, Madhavan KK, Garden OJ, Parks RW,. Association between early systemic inflammatory response, severity of multiorgan dysfunction and death in acute pancreatitis. Br J Surg 2006; 93: 738-744.
15. Tang BM, Eslick GD, Craig JC, McLean AS,. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 2007; 7: 210-217.
16. Szczepanik AM, Scislo L, Scully T, Walewska E, Siedlar M, Kolodziejczyk P, et-al. IL-6 serum levels predict postoperative morbidity in gastric cancer patients. Gastric Cancer 2011; 14: 266-273.
17. Mokart D, Merlin M, Sannini A, Brun JP, Delpero JR, Houvenaeghel G, et-al. Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery. Br J Anaesth 2005; 94: 767-773.
18. Welsch T, Frommhold K, Hinz U, Weigand MA, Kleeff J, Friess H, et-al. Persisting elevation of C-reactive protein after pancreatic resections can indicate developing inflammatory complications. Surgery 2008; 143: 20-28.
19. Adamina M, Warschkow R, Näf F, Hummel B, Rduch T, Lange J, et-al. Monitoring C-reactive protein after laparoscopic colorectal surgery excludes infectious complications and allows for safe and early discharge. Surg Endosc 2014; 29: 2939-2948.
20. Welsch T, Müller SA, Ulrich A, Kischlat A, Hinz U, Kienle P, et-al. C-reactive protein as early predictor for infectious postoperative complications in rectal surgery. Int J Colorectal Dis 2007; 22: 1499-1507.
21. Montagnana M, Minicozzi AM, Salvagno GL, Danese E, Cordiano C, De Manzoni G, et-al. Postoperative variation of C-reactive protein and procalcitonin in patients with gastrointestinal cancer. Clin Lab 2009; 55: 187-192.
22. Korner H, Nielsen HJ, Soreide JA, Nedrebø BS, Søreide K, Knapp JC,. Diagnostic accuracy of C-reactive protein for intraabdominal infections after colorectal resections. J Gastrointest Surg 2009; 13: 1599-1606.
23. Ortega-Deballon P, Radais F, Facy O, d'Athis P, Masson D, Charles PE, et-al. C-reactive protein is an early predictor of septic complications after elective colorectal surgery. World J Surg 2010; 34: 808-814.
24. Dutta S, Fullarton GM, Forshaw MJ, Horgan PG, McMillan DC,. Persistent elevation of C-reactive protein following esophagogastric cancer resection as a predictor of postoperative surgical site infectious complications. World J Surg 2011; 35: 1017-1025.
25. Mackay GJ, Molloy RG, O'Dwyer PJ,. C-reactive protein as a predictor of postoperative infective complications following elective colorectal resection. Colorectal Dis 2011; 13: 583-587.
26. Platt JJ, Ramanathan ML, Crosbie RA, Anderson JH, McKee RF, Horgan PG, et-al. C-reactive protein as a predictor of postoperative infective complications after curative resection in patients with colorectal cancer. Ann Surg Oncol 2012; 19: 4168-4177.
27. Scepanovic MS, Kovacevic B, Cijan V, Antic A, Petrovic Z, Asceric R, et-al. C-reactive protein as an early predictor for anastomotic leakage in elective abdominal surgery. Tech Coloproctol 2013; 17: 541-547.
28. Sax H,; Swiss-NOSO. [ Nationwide surveillance of nosocomial infections in Switzerland-methods and results of the Swiss Nosocomial Infection Prevalence Studies (SNIP) in 1999 and 2002.] Ther Umsch 2004; 61: 197-203.
29. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR,. Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1999; 27: 97-132.
30. Warschkow R, Tarantino I, Torzewski M, Naf F, Lange J, Steffen T,. Diagnostic accuracy of C-reactive protein and white blood cell counts in the early detection of inflammatory complications after open resection of colorectal cancer: a retrospective study of 1187 patients. Int J Colorectal Dis 2011; 26: 1405-1413.
31. Warschkow R, Tarantino I, Ukegjini K, Beutner U, Muller SA, Schmied BM, et-al. Diagnostic study and meta-analysis of C-reactive protein as a predictor of postoperative inflammatory complications after gastroesophageal cancer surgery. Langenbecks Arch Surg 2012; 397: 727-736.
32. Warschkow R, Tarantino I, Folie P, Beutner U, Schmied BM, Bisang P, et-al. C-reactive protein 2-days after laparoscopic gastric bypass surgery reliably indicates leaks and moderately predicts morbidity. J Gastrointest Surg 2012; 16: 1128-1135.
33. Warschkow R, Ukegjini K, Tarantino I, Steffen T, Müller SA, Schmied BM, et-al. Diagnostic study and meta-analysis of C-reactive protein as a predictor of postoperative inflammatory complications after pancreatic surgery. J Hepatobiliary Pancreat Sci 2012; 19: 492-500.
34. Näf F, Warschkow R, Kolb W, Zünd M, Lange J, Steffen T,. Selective decontamination of the gastrointestinal tract in patients undergoing esophageal resection. BMC Surg 2010; 10: 36.
35. Albert PS,. Longitudinal data analysis (repeated measures) in clinical trials. Stat Med 1999; 18: 1707-1732.
36. Goldstein H., Tutorial in biostatistics-longitudinal data analysis (repeated measures) in clinical trials. Stat Med 2000; 19: 1821.
37. Hanley JA, McNeil BJ,. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29-36.
38. DeLong ER, DeLong DM, Clarke-Pearson DL,. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837-845.
39. Agresti A, Coull BA,. Approximate is better than 'exact' for interval estimation of binomial proportions. Am Stat 1998; 52: 119-126.
40. Kester AD, Buntinx F,. Meta-analysis of ROC curves. Med Decis Making 2000; 20: 430-439.
41. Jackson D, Riley R, White IR,. Multivariate meta-analysis: potential and promise. Stat Med 2011; 30: 2481-2498.
42. Whitehead A, Whitehead J,. A general parametric approach to the meta-analysis of randomized clinical trials. Stat Med 1991; 10: 1665-1677.
43. Higgins JP, Thompson SG,. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.
44. Ballesta C, Berindoague R, Cabrera M, Palau M, Gonzales M,. Management of anastomotic leaks after laparoscopic Roux-en- Y gastric bypass. Obes Surg 2008; 18: 623-630.
45. Tschaikowsky K, Hedwig-Geissing M, Braun GG, Radespiel-Troeger M,. Predictive value of procalcitonin, interleukin-6, and C-reactive protein for survival in postoperative patients with severe sepsis. J Crit Care 2011; 26: 54-64.
46. Garcia-Granero A, Frasson M, Flor-Lorente B, Blanco F, Puga R, Carratalá A, et-al. Procalcitonin and C-reactive protein as early predictors of anastomotic leak in colorectal surgery: a prospective observational study. Dis Colon Rectum 2013; 56: 475-483.
47. Takakura Y, Hinoi T, Egi H, Shimomura M, Adachi T, Saito Y, et-al. Procalcitonin as a predictive marker for surgical site infection in elective colorectal cancer surgery. Langenbecks Arch Surg 2013; 398: 833-839.
48. Lagoutte N, Facy O, Ravoire A, Chalumeau C, Jonval L, Rat P, et-al. C-reactive protein and procalcitonin for the early detection of anastomotic leakage after elective colorectal surgery: pilot study in 100 patients. J Visc Surg 2012; 149: e345-e349.
49. Mognol P, Chosidow D, Marmuse JP,. Laparoscopic conversion of laparoscopic gastric banding to Roux-en- Y gastric bypass: a review of 70 patients. Obes Surg 2004; 14: 1349-1353.
50. Owens BM, Owens ML, Hill CW,. Effect of revisional bariatric surgery on weight loss and frequency of complications. Obes Surg 1996; 6: 479-484.
51. te Riele WW, Sze YK, Wiezer MJ, van Ramshorst B,. Conversion of failed laparoscopic gastric banding to gastric bypass as safe and effective as primary gastric bypass in morbidly obese patients. Surg Obes Relat Dis 2008; 4: 735-739.
52. Topart P, Becouarn G, Ritz P,. One-year weight loss after primary or revisional Roux-en- Y gastric bypass for failed adjustable gastric banding. Surg Obes Relat Dis 2009; 5: 459-462.
53. Tucker O, Sucandy I, Szomstein S, Rosenthal RJ,. Revisional surgery after failed laparoscopic adjustable gastric banding. Surg Obes Relat Dis 2008; 4: 740-747.
54. Zingg U, McQuinn A, DiValentino D, Kinsey-Trotman S, Game P, Watson D,. Revisional vs. primary Roux-en- Y gastric bypass-a case-matched analysis: less weight loss in revisions. Obes Surg 2010; 20: 1627-1632.